Inomagen Therapeutics
PrivateLast Round
Seed
Aug 1, 2024
Total Funding Raised
$4.07M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inomagen Therapeutics is a biotechnology company developing a non-viral gene therapy designed to treat the underlying mechanisms of atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inomagen Therapeutics Comparables
Compare Inomagen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rhythm Biotherapeutics | 75% | |
| Renova Therapeutics | 70% | |
| Medera | 66% | |
Inomagen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2024 | ||||
| Convertible Debt | Jan 1, 2023 | ||||
| Grant | Mar 11, 2022 |
Inomagen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Portal Innovations | Convertible Debt |
| Chicago ArchAngels | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 938% MoM, from 128 to 1.3K.
- Aug 1, 2024
Raised $5M in seed funding.
Inomagen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inomagen Therapeutics's valuation, stock price, and market status.